Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30002043
Basic Information
VIS ID
TVIS30002043
Fusion event
HIV-RACGAP1 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr12
Cytoband
q13.12
Reference genome
GRCh37/hg19
Start
50399115/50005332 (Hg38)
End
50399115/50005332 (Hg38)
Orient
-
Location type
Exonic
Fragile sites / regions
FRA12A
Target gene
RACGAP1
miRNAs that regulate target gene
hsa-mir-192-5p
;
hsa-mir-193b-3p
;
hsa-mir-215-5p
;
hsa-mir-26b-5p
;
hsa-mir-16-5p
;
hsa-mir-221-3p
;
hsa-let-7e-5p
;
hsa-mir-208a-5p
;
hsa-mir-576-3p
;
hsa-mir-208b-5p
;
hsa-mir-590-3p
;
hsa-mir-484
;
hsa-mir-3119
;
hsa-mir-3155a
;
hsa-mir-3155b
;
hsa-mir-5006-3p
;
hsa-mir-4755-5p
;
hsa-mir-211-5p
;
hsa-mir-204-5p
;
hsa-mir-623
;
hsa-mir-24-2-5p
;
hsa-mir-24-1-5p
;
hsa-mir-141-5p
;
hsa-mir-3651
;
hsa-mir-140-3p
;
hsa-mir-7159-3p
;
hsa-mir-4503
;
hsa-mir-107
;
hsa-mir-103a-3p
;
hsa-mir-7157-5p
;
hsa-mir-4310
;
hsa-mir-556-5p
;
hsa-mir-382-3p
;
hsa-mir-6838-5p
;
hsa-mir-497-5p
;
hsa-mir-424-5p
;
hsa-mir-195-5p
;
hsa-mir-15b-5p
;
hsa-mir-15a-5p
;
hsa-mir-421
;
hsa-mir-552-5p
;
hsa-mir-3658
;
hsa-mir-302c-5p
;
hsa-mir-4775
;
hsa-mir-3653-3p
;
hsa-mir-6507-5p
;
hsa-mir-527
;
hsa-mir-518a-5p
;
hsa-mir-943
;
hsa-mir-3137
;
hsa-mir-520h
;
hsa-mir-520g-3p
;
hsa-mir-1183
;
hsa-mir-519c-3p
;
hsa-mir-519b-3p
;
hsa-mir-519a-3p
;
hsa-mir-3662
;
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-519d-3p
;
hsa-mir-106a-5p
;
hsa-mir-93-5p
;
hsa-mir-526b-3p
;
hsa-mir-106b-5p
;
hsa-mir-20b-5p
;
hsa-mir-301b-3p
;
hsa-mir-301a-3p
;
hsa-mir-130a-3p
;
hsa-mir-130b-3p
;
hsa-mir-4295
;
hsa-mir-454-3p
;
hsa-mir-3666
;
hsa-mir-19a-3p
;
hsa-mir-19b-3p
;
hsa-mir-892a
;
hsa-mir-3657
;
hsa-mir-4669
;
hsa-mir-4468
;
hsa-mir-6501-3p
;
hsa-mir-2278
;
hsa-mir-5683
;
hsa-mir-6836-3p
;
hsa-mir-5001-3p
;
hsa-mir-7158-5p
;
hsa-mir-6829-3p
;
hsa-mir-6791-3p
;
hsa-mir-6778-3p
;
hsa-mir-4772-3p
;
hsa-mir-6787-3p
;
hsa-mir-1304-3p
;
hsa-mir-4726-3p
;
hsa-mir-6764-5p
;
hsa-mir-1915-3p
;
hsa-mir-6840-3p
;
hsa-mir-6736-3p
;
hsa-mir-6890-3p
;
hsa-mir-122-5p
;
hsa-mir-143-5p
;
hsa-mir-215-3p
;
hsa-mir-3135b
;
hsa-mir-3652
;
hsa-mir-4430
;
hsa-mir-4695-3p
;
hsa-mir-500b-3p
;
hsa-mir-504-3p
;
hsa-mir-564
;
hsa-mir-5693
;
hsa-mir-5698
;
hsa-mir-6499-3p
;
hsa-mir-6773-3p
;
hsa-mir-6879-3p
;
hsa-mir-891a-3p
Nearest miRNA
hsa-mir-1244-3/Upstream/1233295; hsa-let-7i/Downstream/228810;
Nearest TSS
ENST00000382841/Upstream/1061;
ENST00000549792/Downstream/11388;
Nearest CpG islands
None/Target,
chr12-CpG: 104/Upstream/37463
,
chr12-CpG: 41/Downstream/19820
Upstream sequence
AACAACAGATGCAGTTCCTCCACCTTTTGTTCCCAGCATTGCTGCTGGATGGTTGGCCTCTGTTGAGAAAAGCCAGAGCTGATTTTTGCTCCTCGCTTAG
Downstream sequence
TTGAATGCTGCCAGATGTGTCACACATGAGCATCTCTCGAATCAGCTGAATCTGTCGTTCCTACAGACCAAAGCAAAGTAAAACATCATAACTAGCCAGG
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate